Most lately, it's been discovered that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent areas as classical opioid receptors, it binds into a wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts being a scavenger and will not activate a 2nd messenger syst